SCRX

Sciele Pharma and Plethora Solutions Announce Positive Phase III Clinical Results of PSD502 for Premature Ejaculation - 11/07 - 08:00 AM ET

Sciele Pharma Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension - 10/23 - 09:00 AM ET

Plethora completes European Phase III premature ejaculation trial - 10/01 - 09:41 AM ET

SCRX: Positive Data from Ph III Trial in EU of PSD502 for Premature Ejaculation - 09/30 - 03:06 PM ET

Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation - 09/30 - 03:01 PM ET

Sciele Pharma completes Phase III drooling program in pediatric patients - 09/17 - 12:06 PM ET

SCRX: Completes Pivotal Phase III Program for Glycopyrrolate - 09/16 - 09:58 AM ET

Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling - 09/16 - 09:46 AM ET

Sciele and Addrenex report positive results from Phase III ADHD study - 09/11 - 12:06 PM ET

Sciele, Addrenex Cites Positive Results In ADHD Drug Candidate Clonicel Late-Stage Trial - 09/10 - 11:40 PM ET

SCRX: Positive Phase III Clinical Results of Clonicel(R) for ADHD - 09/10 - 02:18 PM ET

Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD - 09/10 - 01:50 PM ET

Sciele Shares Hit Six-Year High On Acceptance Of Japan-Based Shionogi's Buyout Offer - 09/03 - 07:01 AM ET

SCIELE PHARMA INTRADAY TRADE OF $30.60 IS HIGHEST PRICE SINCE JANUARY 2002 - 09/02 - 09:35 AM ET

SCIELE PHARMA VOL 2.4M VS 30-DAY AVG VOL 1.1M - 09/02 - 09:34 AM ET

Sciele Pharma Climbs In Pre-Market On Buyout News - 09/02 - 08:00 AM ET

Shionogi To Acquire Sciele Pharma For $1.4B In Bid To Expand Operations To US Market - 09/02 - 06:26 AM ET

BRIEFING - ASIA HEALTH - SEPT 2, 2008 - 09/02 - 03:45 AM ET

LifeCycle Pharma sells Fenoglide royalty stream to CHRP for $105 million - 08/21 - 08:57 AM ET

Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation - 08/19 - 01:42 PM ET

Page 1 of 8     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index